Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study - Wikidata - awgldk - TriplyDB

Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study

Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study

http://www.wikidata.org/entity/Q24658239

about

High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).Relaxant and anti-inflammatory effect of two thalidomide analogs as PDE-4 inhibitors in pregnant rat uterus Management of preterm labor: atosiban or nifedipine?Tocolysis for preterm labor: expert opinion.Tocolysis for acute preterm labor: does anything work.Nifedipine in the management of preterm labor: a systematic review and metaanalysis Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial)Structure-based lead discovery for protein kinase C zeta inhibitor design by exploiting kinase-inhibitor complex crystal structure data and potential therapeutics for preterm labour.Prevention of preterm labour: 2011 update on tocolysis.The prevention, diagnosis and treatment of premature labor The safety of tocolytics used for the inhibition of preterm labour.β- and β-adrenergic receptors stimulation relaxes porcine myometrium in the peri-implantation period.Medical therapy in the management of preterm birth.The influence of tocolytic drugs on cardiac function, large arteries, and resistance vessels.Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study.Increased Systemic Exposure and Stronger Cardiovascular and Metabolic Adverse Reactions to Fenoterol in Individuals with Heritable OCT1 Deficiency.Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: Individual participant data meta-analysis and health economic analysis.Atrial Fibrillation as a Rare Complication of the Use of Nifedipine as a Tocolytic Agent: A Case Report and Review of the Literature.Anti-inflammatory and utero-relaxant effect of α-bisabolol on the pregnant human uterus.

P2860

Q28551132-C71D0868-6CF2-462E-AF5E-634242083A02 Q33499105-A83B6F97-2516-4DB0-BC42-AAF35FEF8EFE Q33500872-1BDBC63F-4362-4D4B-9E57-16A81041A233 Q33899061-DED61539-F989-4AC4-86DC-9D93F73994C0 Q34272127-2BB5AA42-8F81-46F5-9514-CFFB1B0FCD4B Q34395388-F78AE241-5FF5-4C7F-B67A-95FF478FD29C Q34427660-ACB53934-9375-408D-A2D3-9F42E0449CA9 Q34626694-5498FA10-8548-4F67-B0EA-894157ADCCFE Q35109526-EF13D6D8-04C8-4771-AED8-DD472C0A4BFB Q35328393-32BAA58A-E3F3-4864-A037-86B7EA7EDFAD Q35585283-35CF1A73-F0A3-41F3-9090-DE95661F3FF8 Q36768133-B06FAC14-1D62-48C8-8ED9-EA87465E32D6 Q38829657-56E3D0F7-BE14-4095-B4AF-CE18FFCC79DA Q39145079-5F0E7DF2-F47A-4C7B-9249-1CB14EF45F9F Q43238716-AF206522-9FAB-42AA-8217-A0AEA8D00690 Q43508455-63C8DDC5-7528-4207-BA0A-16386E031B48 Q46977246-B7299DF3-EF46-4EBD-93F7-BB9413E70E84 Q48743258-F67EAF91-C590-407A-8BBD-65F06F3B465F Q53831925-E951381E-294B-458A-8068-2D918FD57B3E Q55266497-4838144D-EBE6-44AA-B429-E6D0769EF2EA Q55380039-0768B9CF-52A7-4803-BC34-527F1D6BC03C

P2860

Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study

http://www.wikidata.org/entity/Q24658239

description

2009 nî lūn-bûn

@nan

2009 թուականին հրատարակուած գիտական յօդուած

@hyw

2009 թվականին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Adverse drug reactions to toco ...... bour: prospective cohort study

@ast

Adverse drug reactions to toco ...... bour: prospective cohort study

@en

Adverse drug reactions to toco ...... bour: prospective cohort study

@nl

type

label

Adverse drug reactions to toco ...... bour: prospective cohort study

@ast

Adverse drug reactions to toco ...... bour: prospective cohort study

@en

Adverse drug reactions to toco ...... bour: prospective cohort study

@nl

prefLabel

Adverse drug reactions to toco ...... bour: prospective cohort study

@ast

Adverse drug reactions to toco ...... bour: prospective cohort study

@en

Adverse drug reactions to toco ...... bour: prospective cohort study

@nl

P1433

Q24658239-D01B15B9-B617-4514-9416-3A881514DA1F

P1476

Q24658239-76853C85-5746-4CCB-93BD-800CBCF95952

P2093

Q24658239-3E5E21AB-9EA6-47FC-B3EE-EED3DC835E16

Q24658239-5844CD68-FC81-44F5-87B1-C2EF89E5B77E

Q24658239-6038DC63-EA41-453E-8900-579A98EDAF54

Q24658239-8C5322BE-FD8B-4DD3-B7BB-1F133E5B662A

Q24658239-8CAB4AE2-45ED-455A-88DD-8DA7020474BA

Q24658239-90F3795A-457D-4251-8D81-F00D5FECA047

Q24658239-B0623873-AB5C-412E-84C5-0F4115A708C1

Q24658239-B7565913-A844-4BDD-82B5-E1F9FDE193A4

Q24658239-C7EBC595-27D1-437F-B7D1-D3362E9A6F93

Q24658239-CB66B6B8-8E6A-4AC7-8C12-D9C3B0FC45FA

P2860

Q24658239-050ED2F6-902B-4658-BD71-DCEF35544233

Q24658239-08B4EF5E-D3FB-4560-B3D1-82A15472A1BA

Q24658239-0D577B51-5655-4FB9-9371-93B627EBE455

Q24658239-12089B1E-89EB-44F8-A4F7-9B61A6F6D566

Q24658239-13A08A40-D48A-4BC5-9E8C-78F48456E173

Q24658239-156F79A7-83C9-4321-B69C-02B67F62E5A1

Q24658239-1A46AD79-3739-4010-BEDB-4F6AAA520E0F

Q24658239-288376C5-B2D1-41BE-9BD0-4E2813CE56C7

Q24658239-3877D0D2-CCE6-41FE-BC91-156E4C031F63

Q24658239-557AA1A5-DAE4-4F67-9354-A46B99B82722

P304

Q24658239-0E0E56FE-8533-468C-8117-76CA71DC5022

P31

Q24658239-EFA00CCA-F128-40E8-A9C3-06FA8BF77871

P356

Q24658239-1019DA97-1ECD-4175-B076-D7AE5FEB066E

P407

Q24658239-A3F7786B-4E76-4E5F-A8AE-CD71E758163F

P433

Q24658239-A78F34D1-890A-4365-B17A-1A6011CD0278

P478

Q24658239-65F08112-E453-4744-98EF-D4FD196DCCB3

P50

Q24658239-35F49866-BAF4-4007-A05B-78E17DE9E96D

P577

Q24658239-808331D7-3478-4D39-8C0D-F802ACCC3F43

P5875

Q24658239-3674098F-FF10-480E-8DD3-67DFEDB94F96

P698

Q24658239-9DEC0D7F-95B4-4E7A-BE0B-5F7AF5896F44

P932

Q24658239-5F20FA60-BB27-446E-8C0F-EA9023572922

P356

P1433

P1476

Adverse drug reactions to toco ...... bour: prospective cohort study

@en

P2093

Ben Willem Mol

http://www.w3.org/2001/XMLSchema#string

Caroline D van Holsbeke

http://www.w3.org/2001/XMLSchema#string

Fred F A M Schobben

http://www.w3.org/2001/XMLSchema#string

Gerard H A Visser

http://www.w3.org/2001/XMLSchema#string

Herman P van Geijn

http://www.w3.org/2001/XMLSchema#string

Jan-Jaap H M Erwich

http://www.w3.org/2001/XMLSchema#string

Johannes J Duvekot

http://www.w3.org/2001/XMLSchema#string

Linda Härmark

http://www.w3.org/2001/XMLSchema#string

Myriam Hanssens

http://www.w3.org/2001/XMLSchema#string

Roel de Heus

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclo-oxygenase (COX) inhibitors for treating preterm labour

Betamimetics for inhibiting preterm labour

Calcium channel blockers for inhibiting preterm labour

The great tocolytic debate: some pitfalls in the study of safety.

Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.

Prophylactic corticosteroids for preterm birth.

Prevention of preterm delivery.

Oxytocin antagonists for tocolysis in preterm labour -- a systematic review.

Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.

Acute myocardial infarction during pregnancy.

P304

b744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.B744

http://www.w3.org/2001/XMLSchema#string

P407

P433

mar05 2

http://www.w3.org/2001/XMLSchema#string

P478

338

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24180664

http://www.w3.org/2001/XMLSchema#string

P698

19264820

http://www.w3.org/2001/XMLSchema#string

P932

2654772

http://www.w3.org/2001/XMLSchema#string